Background End-stage kidney disease is a leading cause of morbidity and mortality worldwide.
Prevalence of the disease and worldwide use of renal replacement therapy (RRT) are …

Background— Early trials evaluating the effect of omega 3 fatty acids (ω-3 FA) reported
benefits for mortality and cardiovascular events but recent larger studies trials have variable …

Aim Elderly people comprise a large and growing proportion of the global dialysis population.
Regional differences in rates of dialysis in the elderly suggest multiple factors influence …

Background Sparsentan is a novel, non-immunosuppressive, single-molecule, dual
endothelin and angiotensin receptor antagonist being examined in an ongoing phase 3 trial in …

Results Seventeen systemic arteriovenous fistula-attributable infections were documented in
90 patients who were followed for 3765 arteriovenous fistula-months. Compared with rope …

The article focuses on the Kidney Health Australia Caring for Australians with Renal
Impairment (KHA-CARI) adaptation of the Kidney Disease Improving Global Outcomes (KDIGO) …

Aim To explore the current practices related to the insertion, management and removal of
dialysis central venous catheters (CVCs) used in patients with chronic kidney disease …

To compare different deep learning architectures for predicting the risk of readmission
within 30 days of discharge from the intensive care unit (ICU). The interpretability of attention-…

Objective To determine whether disrupting the renin angiotensin system with angiotensin
receptor blockers will improve clinical outcomes in people with covid-19. Design CLARITY was …

Objective To identify whether multifaceted interventions, or care bundles, reduce catheter
related bloodstream infections (CRBSIs) from central venous catheters used for haemodialysis. …